Bucelon 60mg Injection

Bucelon 60mg Injection is an antineoplastic chemotherapy drug belonging to the alkylating agent class, specifically an alkyl sulfonate. It is indicated for treating blood cancers, including chronic myelogenous leukemia, a type of cancer characterised by increased white blood cell production in the bone marrow. It is also used as conditioning therapy prior to allogeneic stem cell transplantation, where patients with destroyed bone marrow stem cells receive healthy blood-forming cells from a donor to restore haematopoietic function after radiation or high-dose chemotherapy.

Chronic myelogenous leukemia is an uncommon malignancy affecting bone marrow, the soft spongy tissue responsible for producing blood cells, resulting in elevated white blood cell counts.

Common adverse effects of Bucelon 60mg Injection include leucopenia (decreased white blood cell count), dizziness, dyspnoea, oral mucositis, nausea, diarrhoea, insomnia, skin rash, and fever. Adequate fluid intake is recommended during treatment.

Bucelon 60mg Injection can cause severe bone marrow suppression. Concomitant use with other prescribed or non-prescribed medications that reduce blood cell counts requires discussion with your healthcare professional prior to administration. The drug affects immune function, increasing susceptibility to infections, including serious or fatal infections. Contact your doctor if you develop fever, chills, cough, oral ulceration, or unexplained bleeding or bruising.

Hematopoietic progenitor cell transplantation Chronic myelogenous leukemia Polycythaemia vera (a type of cancer that causes an increase in red blood cells) Thrombocythemia (increased number of platelets in the blood) Myelofibrosis (type of blood cancer where scar tissues are formed in bone marrow) Hemoglobinopathies (a genetic disorder that produces abnormal hemoglobin) Brain Malignancies

Bucelon 60 mg injection works by interfering with the DNA replication process, which is necessary for the cells to divide. It stops tumor growth by inhibiting cell division. It causes cytotoxicity by reversibly binding to nucleophilic groups on different cell components. Alkylation of DNA is most likely the crucial cytotoxic reaction that kills tumor cells. It damages the DNA and RNA of the cancer cells by stopping their growth and multiplication. They are combined with other medications to treat various lymphatic and solid cancers.

Your physician will decide the formulation, dose, and duration of this therapy. The dose of Bucelon 60 mg injection depends on your blood cancer. If you are prescribed the injection, your healthcare professional will administer the injection. Do not self-administer. The injection is administered as an intravenous infusion into the vein. Don't stop the medication until or unless your doctor advises. If you missed the dose, do not take double the doses. Inform your physician about your missed dose.

Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them. Bucelon 60 mg injection causes the following side effects Severe Myelosuppression (decreased bone marrow activity) Common side effects Thalassemia Skin rashes Hair loss Patches of dark skin Blood in urine Decrease in the number of blood cells and platelets Nausea and vomiting Jaundice Infertility and sterility Pneumonia Syndrome Itching

Inform the doctor if the patient has taken radiotherapy priorly to the treatment. If you have any other medical conditions like heart disease, lung, kidney, or liver problems. Tell your doctor if you have any symptoms of gout (pain and swollen joints caused by uric acid crystals). During or after administration of the injection, if you face itchy skin, fever, excessive sweating, rigors or chills, or difficulty in breathing, inform your doctor immediately.